1. Home
  2. PODD vs ES Comparison

PODD vs ES Comparison

Compare PODD & ES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • ES
  • Stock Information
  • Founded
  • PODD 2000
  • ES 1927
  • Country
  • PODD United States
  • ES United States
  • Employees
  • PODD N/A
  • ES N/A
  • Industry
  • PODD Medical/Dental Instruments
  • ES Electric Utilities: Central
  • Sector
  • PODD Health Care
  • ES Utilities
  • Exchange
  • PODD Nasdaq
  • ES Nasdaq
  • Market Cap
  • PODD 21.5B
  • ES 23.7B
  • IPO Year
  • PODD 2007
  • ES N/A
  • Fundamental
  • Price
  • PODD $278.58
  • ES $66.08
  • Analyst Decision
  • PODD Strong Buy
  • ES Hold
  • Analyst Count
  • PODD 19
  • ES 10
  • Target Price
  • PODD $320.11
  • ES $65.56
  • AVG Volume (30 Days)
  • PODD 504.7K
  • ES 2.0M
  • Earning Date
  • PODD 08-07-2025
  • ES 07-31-2025
  • Dividend Yield
  • PODD N/A
  • ES 4.57%
  • EPS Growth
  • PODD 67.46
  • ES N/A
  • EPS
  • PODD 5.55
  • ES 2.35
  • Revenue
  • PODD $2,198,900,000.00
  • ES $12,991,135,000.00
  • Revenue This Year
  • PODD $24.54
  • ES $14.63
  • Revenue Next Year
  • PODD $17.48
  • ES $2.91
  • P/E Ratio
  • PODD $50.63
  • ES $28.07
  • Revenue Growth
  • PODD 23.48
  • ES 14.44
  • 52 Week Low
  • PODD $173.00
  • ES $52.28
  • 52 Week High
  • PODD $329.33
  • ES $69.01
  • Technical
  • Relative Strength Index (RSI)
  • PODD 38.53
  • ES 53.39
  • Support Level
  • PODD $282.75
  • ES $65.22
  • Resistance Level
  • PODD $290.25
  • ES $66.83
  • Average True Range (ATR)
  • PODD 5.49
  • ES 1.02
  • MACD
  • PODD 0.05
  • ES -0.05
  • Stochastic Oscillator
  • PODD 2.88
  • ES 57.30

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About ES Eversource Energy (D/B/A)

Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electric and gas distribution service to more than 4 million customers in the Northeast US. The company plans to sell its water utility, Aquarion, in 2025. Eversource expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast US. The company exited most of its unregulated businesses in 2006.

Share on Social Networks: